KRT88P and cancer: Moreover, the major HBV treatment guidelines proposals originating from America, Europe, and the Asia-Pacific region, recommended that all cancer patients should check HBV markers, including HBsAg and anti-HBc, prior to initiation of chemotherapy, and to use routine prophylactic antiviral therapy for individuals who are positive for HBsAg before the start of cancer chemotherapy [28–30].